Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce L Jones

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Public Health|April 8, 2026
Projected Increase in HIV Incidence in 11 States if Ryan White Ends: A Simulation StudyMelissa Schnure, Ryan Forster, Joyce L Jones, et al.
Open Forum Infectious Diseases|December 7, 2023
Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With MpoxWilliam M Garneau, Joyce L Jones, Gabriella M Dashler, et al.
Journal of Virological Methods|August 10, 2024
Discordant performance of mpox serological assaysJoanne H Hunt, Joyce L Jones, Kelly A Gebo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2025
The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of Human Immunodeficiency Virus Nucleic Acid Assays in the United StatesYukari C Manabe, Matthew M Hamill, Kara M Palamountain, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2025
Generating Evidence for Effective HIV Implementation at Scale: The Value and Feasibility of a Network for Implementation Science in HIVSheree Schwartz, Nanette Benbow, Russell A Brewer, et al.
The Journal of Infectious Diseases|June 28, 2023
Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox PatientsCaroline C Traut, Joyce L Jones, Renata A Sanders, et al.
Science Translational Medicine|August 13, 2025
Proviruses in CD4<sup>+</sup> T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremiaFengting Wu, Milica Moskovljevic, Filippo Dragoni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2025
Policymaker Perspectives on Implementation Determinants of Rapid ART and Same-Day PrEP in Seven Priority Jurisdictions for Ending the HIV Epidemic: A Multisite Qualitative StudyAnna-Sophia Katomski, Ana Michaela Pachicano, Alithia Zamantakis, et al.
AIDS and Behavior|October 10, 2025
Barriers to Same-Day Pre-exposure Prophylaxis (PrEP) Implementation in Federally Funded HIV Clinics Within High-Burden Areas of the U.S.: A Coincidence AnalysisAlithia Zamantakis, Wilson Gomez, Lipin Lukose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2020
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019Dima Dandachi, Grant Geiger, Mary W Montgomery, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Public Health|April 8, 2026
Projected Increase in HIV Incidence in 11 States if Ryan White Ends: A Simulation StudyMelissa Schnure, Ryan Forster, Joyce L Jones, et al.
Open Forum Infectious Diseases|December 7, 2023
Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With MpoxWilliam M Garneau, Joyce L Jones, Gabriella M Dashler, et al.
Journal of Virological Methods|August 10, 2024
Discordant performance of mpox serological assaysJoanne H Hunt, Joyce L Jones, Kelly A Gebo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2025
The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of Human Immunodeficiency Virus Nucleic Acid Assays in the United StatesYukari C Manabe, Matthew M Hamill, Kara M Palamountain, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2025
Generating Evidence for Effective HIV Implementation at Scale: The Value and Feasibility of a Network for Implementation Science in HIVSheree Schwartz, Nanette Benbow, Russell A Brewer, et al.
The Journal of Infectious Diseases|June 28, 2023
Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox PatientsCaroline C Traut, Joyce L Jones, Renata A Sanders, et al.
Science Translational Medicine|August 13, 2025
Proviruses in CD4<sup>+</sup> T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremiaFengting Wu, Milica Moskovljevic, Filippo Dragoni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2025
Policymaker Perspectives on Implementation Determinants of Rapid ART and Same-Day PrEP in Seven Priority Jurisdictions for Ending the HIV Epidemic: A Multisite Qualitative StudyAnna-Sophia Katomski, Ana Michaela Pachicano, Alithia Zamantakis, et al.
AIDS and Behavior|October 10, 2025
Barriers to Same-Day Pre-exposure Prophylaxis (PrEP) Implementation in Federally Funded HIV Clinics Within High-Burden Areas of the U.S.: A Coincidence AnalysisAlithia Zamantakis, Wilson Gomez, Lipin Lukose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2020
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019Dima Dandachi, Grant Geiger, Mary W Montgomery, et al.
Pageof 4